Literature DB >> 29098549

The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.

Yanhua Li1, Junjiao Gu1, Hong Lu2.   

Abstract

BACKGROUND: Several lines of evidence have indicated that growth arrest-specific transcript 5 (GAS5) functions as a tumor suppressor and is aberrantly expressed in multiple cancers. GAS5 was found to be downregulated in gastric cancer (GC) tissues, and ectopic expression of GAS5 inhibited GC cell proliferation. AIMS: The present study aimed to explore the underlying mechanisms of GAS5 involved in GC cell proliferation.
METHODS: GAS5 and miR-222 expressions in GC cell lines were estimated by quantitative real-time polymerase chain reaction. The effects of GAS5 and miR-222 on GC cell proliferation were assessed by MTT assay and 5-bromo-2-deoxyuridine (BrdU) incorporation assays. The interaction between GAS5 and miR-222 was confirmed by luciferase reporter assay and RNA immunoprecipitation assay. The protein levels of the phosphatase and tensin homolog (PTEN), phosphorylated protein kinase B (Akt) (p-Akt), Akt, phosphorylated mammalian target of rapamycin (mTOR) (p-mTOR), and mTOR were determined by western blot.
RESULTS: GAS5 was downregulated and miR-222 was upregulated in GC cells. GAS5 directly targeted and suppressed miR-222 expression. GAS5 overexpression and miR-222 inhibition suppressed cell proliferation, increased PTEN protein level and decreased p-Akt and p-mTOR protein levels in GC cells while GAS5 knockdown and miR-222 overexpression exhibited the opposite effects. Moreover, mechanistic analyses revealed that GAS5 regulated GC cell proliferation through the PTEN/Akt/mTOR pathway by negatively regulating miR-222.
CONCLUSIONS: GAS5/miR-222 axis regulated proliferation of GC cells through the PTEN/Akt/mTOR pathway, which facilitated the development of lncRNA-directed therapy against this deadly disease.

Entities:  

Keywords:  GAS5; Gastric cancer; PTEN/Akt/mTOR pathway; Proliferation; miR-222

Mesh:

Substances:

Year:  2017        PMID: 29098549     DOI: 10.1007/s10620-017-4831-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  45 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

2.  Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21.

Authors:  Litian Hu; Hua Ye; Guangming Huang; Fei Luo; Yawei Liu; Yi Liu; Xiaojun Yang; Jian Shen; Qizhan Liu; Jianping Zhang
Journal:  Tumour Biol       Date:  2015-09-24

3.  Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.

Authors:  Richard I Gregory; Thimmaiah P Chendrimada; Neil Cooch; Ramin Shiekhattar
Journal:  Cell       Date:  2005-11-03       Impact factor: 41.582

Review 4.  MicroRNAs as potential biomarkers for gastric cancer.

Authors:  Han-Shao Liu; Hua-Sheng Xiao
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 5.  miR221/222 in cancer: their role in tumor progression and response to therapy.

Authors:  M Garofalo; C Quintavalle; G Romano; C M Croce; G Condorelli
Journal:  Curr Mol Med       Date:  2012-01       Impact factor: 2.222

6.  Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK.

Authors:  Na Li; Bin Tang; En-Dong Zhu; Bo-sheng Li; Yuan Zhuang; Shu Yu; Dong-shui Lu; Quan-Ming Zou; Bin Xiao; Xu-Hu Mao
Journal:  FEBS Lett       Date:  2012-02-02       Impact factor: 4.124

7.  miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway.

Authors:  Bailong Li; Ying Lu; Honghai Wang; Xiaocui Han; Jun Mao; Jiazhi Li; Lihui Yu; Bo Wang; Shujun Fan; Xiaotang Yu; Bo Song
Journal:  Biomed Pharmacother       Date:  2016-02-17       Impact factor: 6.529

Review 8.  Small silencing RNAs: an expanding universe.

Authors:  Megha Ghildiyal; Phillip D Zamore
Journal:  Nat Rev Genet       Date:  2009-02       Impact factor: 53.242

9.  The hormone response element mimic sequence of GAS5 lncRNA is sufficient to induce apoptosis in breast cancer cells.

Authors:  Mark R Pickard; Gwyn T Williams
Journal:  Oncotarget       Date:  2016-03-01

10.  LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells.

Authors:  Chen Guo; Wei-Qi Song; Ping Sun; Lian Jin; Hong-Yan Dai
Journal:  J Biomed Sci       Date:  2015-10-29       Impact factor: 8.410

View more
  22 in total

Review 1.  Potentials of lncRNA-miRNA-mRNA networks as biomarkers for laryngeal squamous cell carcinoma.

Authors:  Yan Lv; Yanhua Wang; Zhikai Zhang
Journal:  Hum Cell       Date:  2022-10-01       Impact factor: 4.374

Review 2.  Research Progress of Long Non-Coding RNA GAS5 in Malignant Tumors.

Authors:  Guohong Lin; Tianzhun Wu; Xing Gao; Ziqin He; Wenwei Nong
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

Review 3.  Research updates on the clinical implication of long noncoding RNA in digestive system cancers and chemoresistance.

Authors:  Xinzhi Miao; Fang Wang; Tianyun Wang; Siti Razila Abdul Razak; Muhammad Amir Yunus; Ida Shazrina Ismail
Journal:  3 Biotech       Date:  2021-09-01       Impact factor: 2.893

Review 4.  Noncoding RNA:RNA Regulatory Networks in Cancer.

Authors:  Jia Jia Chan; Yvonne Tay
Journal:  Int J Mol Sci       Date:  2018-04-27       Impact factor: 5.923

Review 5.  LONG-NONCODING RNAs in gastroesophageal cancers.

Authors:  Giuseppe Nicolò Fanelli; Pierluigi Gasparini; Irene Coati; Ri Cui; Hubert Pakula; Basudev Chowdhury; Nicola Valeri; Fotios Loupakis; Juozas Kupcinskas; Rocco Cappellesso; Matteo Fassan
Journal:  Noncoding RNA Res       Date:  2018-11-01

6.  LncRNA GAS5-mediated miR-1323 promotes tumor progression by targeting TP53INP1 in hepatocellular carcinoma.

Authors:  Fengjuan Zhang; Chao Yang; Zhiyuan Xing; Pei Liu; Bo Zhang; Xiang Ma; Liuye Huang; Likun Zhuang
Journal:  Onco Targets Ther       Date:  2019-05-21       Impact factor: 4.147

Review 7.  Autophagy-Modulating Long Non-coding RNAs (LncRNAs) and Their Molecular Events in Cancer.

Authors:  Md Zahirul Islam Khan; Shing Yau Tam; Helen Ka Wai Law
Journal:  Front Genet       Date:  2019-01-14       Impact factor: 4.599

Review 8.  Emerging role of long non-coding RNA in the development of gastric cancer.

Authors:  Hang Yu; Long Rong
Journal:  World J Gastrointest Oncol       Date:  2018-09-15

9.  lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic Cancer.

Authors:  Bingyan Liu; Shaoqiu Wu; Jun Ma; Shuo Yan; Zhengguang Xiao; Linhuang Wan; Feng Zhang; Mingyi Shang; Aiwu Mao
Journal:  Mol Ther Nucleic Acids       Date:  2018-10-06       Impact factor: 8.886

Review 10.  Role of MicroRNAs Induced by Chinese Herbal Medicines Against Hepatocellular Carcinoma: A Brief Review.

Authors:  Ge Guo; Juhua Zhou; Xiaogaung Yang; Jiang Feng; Yanxia Shao; Tingting Jia; Qingrong Huang; Yanmin Li; Yin Zhong; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Integr Cancer Ther       Date:  2018-10-20       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.